Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Ju Lee H, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Pinnix CC, et al. Among authors: esmaeli b. Head Neck. 2018 Jun;40(6):1335. doi: 10.1002/hed.25149. Epub 2018 Feb 21. Head Neck. 2018. PMID: 29851218 No abstract available.
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Pinnix CC, et al. Among authors: esmaeli b. Head Neck. 2017 Jun;39(6):1095-1100. doi: 10.1002/hed.24717. Epub 2017 Apr 3. Head Neck. 2017. PMID: 28370694 Free PMC article.
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Pinnix CC, et al. Among authors: esmaeli b. Head Neck. 2019 May;41(5):1546. doi: 10.1002/hed.25738. Epub 2019 Mar 19. Head Neck. 2019. PMID: 30990235 No abstract available.
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
Thuro BA, Ning J, Peng SA, Pace ST, Dudeja G, Ozgur O, Turturro F, Samaniego F, Hagemeister FB, Fayad LE, Fowler NH, Pinnix CC, Debnam JM, Esmaeli B. Thuro BA, et al. Among authors: esmaeli b. Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):355-360. doi: 10.1097/IOP.0000000000000789. Ophthalmic Plast Reconstr Surg. 2017. PMID: 27636243
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Esmaeli B, McLaughlin P, Pro B, Samaniego F, Gayed I, Hagemeister F, Romaguera J, Cabanillas F, Neelapu SS, Banay R, Fayad L, Wayne Saville M, Kwak LW. Esmaeli B, et al. Ann Oncol. 2009 Apr;20(4):709-14. doi: 10.1093/annonc/mdn692. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150940 Free article.
331 results